GB Patent

GB2520008A — Injector Device and Base Station

Assigned to Cambridge Consultants Ltd · Expires 2015-05-13 · 11y expired

What this patent protects

An injector device 200 for use with a syringe (150, fig 1a) holding a medicament is disclosed. The syringe is accommodated within a housing 205 and the device includes means such as a piston 255 for advancing the plunger of the syringe, when accommodated in the housing, to expel …

USPTO Abstract

An injector device 200 for use with a syringe (150, fig 1a) holding a medicament is disclosed. The syringe is accommodated within a housing 205 and the device includes means such as a piston 255 for advancing the plunger of the syringe, when accommodated in the housing, to expel the medicament held by the syringe. Mechanical energy for driving the plunger advancing means is transferred, optionally by keyed recess 545, form an external source such as a base station (900, fig 9) and stored in the device, optionally by a spring 251. A trigger 253 is used to trigger the plunger of the syringe, when accommodated in the housing, to expel the medicament held by the syringe using the stored energy. In another aspect, a base station for the injector is provided. In a further aspect, a handling element for use with a syringe is also provided.

Drugs covered by this patent

Patent Metadata

Patent number
GB2520008A
Jurisdiction
GB
Classification
Expires
2015-05-13
Drug substance claim
No
Drug product claim
No
Assignee
Cambridge Consultants Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.